Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novozymes A/S    NZYM B   DK0060336014

NOVOZYMES A/S

(NZYM B)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 12/01 10:55:00 am
352.4 DKK   -1.26%
11/23NOVOZYMES A/S : Change of management
AQ
10/22NOVOZYMES A/S : Trading by management and close relations of management
AQ
10/21NOVOZYMES A/S : Interim report for the first nine months of 2020
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
11/25/2020 11/26/2020 11/27/2020 11/30/2020 12/01/2020 Date
355.2(c) 356.4(c) 359.3(c) 356.9(c) 350.3(c) Last
500 002 396 118 353 768 1 414 481 816 652 Volume
+0.65% +0.34% +0.81% -0.67% -1.85% Change
More quotes
Financials
Sales 2020 14 164 M 2 298 M 2 298 M
Net income 2020 2 884 M 468 M 468 M
Net Debt 2020 4 337 M 704 M 704 M
P/E ratio 2020 34,2x
Yield 2020 1,54%
Sales 2021 14 635 M 2 374 M 2 374 M
Net income 2021 3 030 M 492 M 492 M
Net Debt 2021 4 439 M 720 M 720 M
P/E ratio 2021 31,9x
Yield 2021 1,63%
Capitalization 98 167 M 15 879 M 15 925 M
EV / Sales 2020 7,24x
EV / Sales 2021 7,01x
Nbr of Employees 6 180
Free-Float 72,3%
More Financials
Company
Novozymes AS is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market are as follows: - domestic cleaning and servicing products industry (33.1%); - food industry (29%); - bioenergy (19.6%); - agriculture and animal feed industry (13.1%): enzymes used to improve the productivity and digestion of foods; - wastewater treatment and technical industry (5. 
Sector
Specialty Chemicals
Calendar
02/02Earnings Release
More about the company
Notations Surperformance© of Novozymes A/S
Trading Rating : Investor Rating :
More Ratings
All news about NOVOZYMES A/S
11/23NOVOZYMES A/S : Change of management
AQ
10/22NOVOZYMES A/S : Trading by management and close relations of management
AQ
10/21NOVOZYMES A/S : Interim report for the first nine months of 2020
AQ
10/21NOVOZYMES A/S : Press Release
CO
10/21NOVOZYMES A/S : Nomination
CO
10/16NOVOZYMES A/S : quaterly earnings release
09/30NOVOZYMES A/S : 3rd quarter report
CO
09/22Government Initiatives to Push the Global Direct-fed Microbials Market to Gar..
AQ
09/16NOVOZYMES A/S : New biological platform converts corn fiber into ethanol
PU
09/09BEYOND “99.9%” CLAIMS : Novozymes launches probiotic solution in cle..
PU
09/02NOVOZYMES A/S : Trading by management and close relations of management
AQ
09/01NOVOZYMES A/S : Changes to management
AQ
08/17NOVOZYMES A/S : Trading by management and close relations of management
AQ
08/17NOVOZYMES A/S : Transactions under Novozymes' stock buyback program
AQ
08/12GLOBAL MARKETS LIVE: Cisco, Orsted, Foxconn…
More news
News in other languages on NOVOZYMES A/S
11/13Bourse Zurich: le SMI termine la semaine sans entrain
11/13Résumé des principales informations économiques du vendredi 13 novembre 2020
11/13DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 13.11.2020 - 15.15 Uhr
11/13Bourse Zurich: toujours en quête de direction à l'approche de la mi-journée
11/13Bourse Zurich: la Bourse suisse entame la séance sans direction
More news
Analyst Recommendations on NOVOZYMES A/S
More recommendations
Chart NOVOZYMES A/S
Duration : Period :
Novozymes A/S Technical Analysis Chart | NZYM B | DK0060336014 | MarketScreener
Technical analysis trends NOVOZYMES A/S
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 20
Average target price 354,05 DKK
Last Close Price 350,30 DKK
Spread / Highest target 31,3%
Spread / Average Target 1,07%
Spread / Lowest Target -18,6%
EPS Revisions
Managers
NameTitle
Ester Baiget President & Chief Executive Officer
Jørgen Buhl Rasmussen Chairman
Graziela Chaluppe dos Santos Malucelli Chief Operating Officer & Executive VP
Lars Green Chief Financial Officer & Executive Vice President
Claus Crone Fuglsang Chief Scientific Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
NOVOZYMES A/S9.48%16 054
ECOLAB INC.15.11%63 412
GIVAUDAN SA22.20%37 720
SIKA AG27.52%36 269
EMS-CHEMIE HOLDING AG30.48%21 434
SYMRISE AG11.94%16 995